Long-Term Outcomes After Hepatectomy for Alveolar Echinococcosis in Immunosuppressed Patients
Pathogens · 2026
DOI: 10.3390/pathogens15070756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Djana Rrupa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland. Hauptthemen laut MEDLINE: Hepatectomy, Immunocompromised Host, Echinococcosis, Hepatic, Echinococcosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Long-term outcomes after hepatectomy for alveolar echinococcosis (AE) in immunosuppressed patients remain poorly investigated. This study evaluated recurrence rates and recurrence-free/overall survivals (RFS/OS) after AE resection in immunocompromised and immunocompetent patients. Consecutive patients operated for liver AE in two university hospitals were retrospectively collected (2000–2021). Immunosuppressed patients were defined as patients who had a reduced ability to fight infection due to certain diseases or treatments. 195 patients had hepatectomy for liver AE. Preoperative albendazole was given in 111 cases (57%). Fifty-two patients (27%) were considered immunosuppressed. Patients in the immunosuppressed and immunocompetent cohorts had similar preoperative characteristics. Recurrences occurred in 10 patients (immunosuppressed group: 4, non-immunosuppressed group: 6) within a median follow-up of 58 months (95%CI 48–68). No significant differences in RFS and OS were found between the immunosuppressed and immunocompetent groups (212 vs. 206 months, p = 0.625 and 236 vs. 210 months, p = 0.282). Two-year recurrence rates were 0% in the immunosuppressed cohort and 1% (1/142) in the immunocompetent patients (p = 0.466). Absence of preoperative albendazole and lesion size were predictive of recurrence after hepatectomy. Immunosuppression was not found to be a risk factor for recurrence (HR 1.4, p = 0.626). In this bicentric study, immunocompromised patients did not have significantly different recurrence rates, RFS, and OS than immunocompetent patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.
- Department of Visceral Surgery and Medicine, Inselspital-Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
- Department of General, Visceral, and Transplant Surgery, Muenster University Hospital, 48149 Muenster, Germany.
ORCID-Profile: Djana Rrupa, Emilie Uldry, Guido Beldi, Severin Gloor, Anja Lachenmayer, Gaëtan-Romain Joliat
Zitieren
APA
Rrupa, D., Kaiser, C., Melloul, E., Uldry, E., Halkic, N., Beldi, G., Gloor, S., Lachenmayer, A., & Joliat, G. R. (2026). Long-Term Outcomes After Hepatectomy for Alveolar Echinococcosis in Immunosuppressed Patients. Pathogens. https://doi.org/10.3390/pathogens15070756
Vancouver
Rrupa D, Kaiser C, Melloul E, Uldry E, Halkic N, Beldi G, et al. Long-Term Outcomes After Hepatectomy for Alveolar Echinococcosis in Immunosuppressed Patients. Pathogens. 2026. doi:10.3390/pathogens15070756
BibTeX
@article{Rrupa2026,
author = {Rrupa, Djana and Kaiser, Christelle and Melloul, Emmanuel and Uldry, Emilie and Halkic, Nermin and Beldi, Guido and Gloor, Severin and Lachenmayer, Anja and Joliat, Gaëtan-Romain},
title = {Long-Term Outcomes After Hepatectomy for Alveolar Echinococcosis in Immunosuppressed Patients},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15070756}
}
EUVIMED